Performance of 4 Point‐of‐Care Screening Tests for Feline Leukemia Virus and Feline Immunodeficiency Virus
Background More than 3 million cats in the United States are infected with FeLV or FIV. The cornerstone of control is identification and segregation of infected cats. Hypothesis/Objectives To compare test performance with well‐characterized clinical samples of currently available FeLV antigen/FIV an...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-03-01
|
Series: | Journal of Veterinary Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1111/jvim.14648 |
_version_ | 1811344080792190976 |
---|---|
author | J.K. Levy P. Cynda Crawford S.J. Tucker |
author_facet | J.K. Levy P. Cynda Crawford S.J. Tucker |
author_sort | J.K. Levy |
collection | DOAJ |
description | Background More than 3 million cats in the United States are infected with FeLV or FIV. The cornerstone of control is identification and segregation of infected cats. Hypothesis/Objectives To compare test performance with well‐characterized clinical samples of currently available FeLV antigen/FIV antibody combination test kits. Animals Surplus serum and plasma from diagnostic samples submitted by animal shelters, diagnostic laboratories, veterinary clinics, and cat research colonies. None of the cats had been vaccinated against FIV. The final sample set included 146 FeLV+, 154 FeLV−, 94 FIV+, and 97 FIV− samples. Methods Prospective, blind comparison to a gold standard: Samples were evaluated in 4 different point‐of‐care tests by ELISA antigen plate tests (FeLV) and virus isolation (FIV) as the reference standards. All test results were visually read by 2 blinded observers. Results Sensitivity and specificity, respectively, for FeLV were SNAP® (100%/100%), WITNESS® (89.0%/95.5%), Anigen® (91.8%/95.5%), and VetScan® (85.6%/85.7%). Sensitivity and specificity for FIV were SNAP® (97.9%/99.0%), WITNESS® (94.7%/100%), Anigen® (96.8%/99.0%), and VetScan® (91.5%/99.0%). Conclusions and Clinical Importance The SNAP® test had the best performance for FeLV, but there were no significant differences for FIV. In typical cat populations with seroprevalence of 1–5%, a majority of positive results reported by most point‐of‐care test devices would be false‐positives. This could result in unnecessary segregation or even euthanasia. |
first_indexed | 2024-04-13T19:41:32Z |
format | Article |
id | doaj.art-b6ca4f31c2e14a49bc6e2cad839e16ea |
institution | Directory Open Access Journal |
issn | 0891-6640 1939-1676 |
language | English |
last_indexed | 2024-04-13T19:41:32Z |
publishDate | 2017-03-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Veterinary Internal Medicine |
spelling | doaj.art-b6ca4f31c2e14a49bc6e2cad839e16ea2022-12-22T02:32:52ZengWileyJournal of Veterinary Internal Medicine0891-66401939-16762017-03-0131252152610.1111/jvim.14648Performance of 4 Point‐of‐Care Screening Tests for Feline Leukemia Virus and Feline Immunodeficiency VirusJ.K. Levy0P. Cynda Crawford1S.J. Tucker2Maddie's Shelter Medicine Program College of Veterinary Medicine University of Florida Gainesville FLMaddie's Shelter Medicine Program College of Veterinary Medicine University of Florida Gainesville FLMaddie's Shelter Medicine Program College of Veterinary Medicine University of Florida Gainesville FLBackground More than 3 million cats in the United States are infected with FeLV or FIV. The cornerstone of control is identification and segregation of infected cats. Hypothesis/Objectives To compare test performance with well‐characterized clinical samples of currently available FeLV antigen/FIV antibody combination test kits. Animals Surplus serum and plasma from diagnostic samples submitted by animal shelters, diagnostic laboratories, veterinary clinics, and cat research colonies. None of the cats had been vaccinated against FIV. The final sample set included 146 FeLV+, 154 FeLV−, 94 FIV+, and 97 FIV− samples. Methods Prospective, blind comparison to a gold standard: Samples were evaluated in 4 different point‐of‐care tests by ELISA antigen plate tests (FeLV) and virus isolation (FIV) as the reference standards. All test results were visually read by 2 blinded observers. Results Sensitivity and specificity, respectively, for FeLV were SNAP® (100%/100%), WITNESS® (89.0%/95.5%), Anigen® (91.8%/95.5%), and VetScan® (85.6%/85.7%). Sensitivity and specificity for FIV were SNAP® (97.9%/99.0%), WITNESS® (94.7%/100%), Anigen® (96.8%/99.0%), and VetScan® (91.5%/99.0%). Conclusions and Clinical Importance The SNAP® test had the best performance for FeLV, but there were no significant differences for FIV. In typical cat populations with seroprevalence of 1–5%, a majority of positive results reported by most point‐of‐care test devices would be false‐positives. This could result in unnecessary segregation or even euthanasia.https://doi.org/10.1111/jvim.14648CatsDiagnosisPCRRetrovirusVirus culture |
spellingShingle | J.K. Levy P. Cynda Crawford S.J. Tucker Performance of 4 Point‐of‐Care Screening Tests for Feline Leukemia Virus and Feline Immunodeficiency Virus Journal of Veterinary Internal Medicine Cats Diagnosis PCR Retrovirus Virus culture |
title | Performance of 4 Point‐of‐Care Screening Tests for Feline Leukemia Virus and Feline Immunodeficiency Virus |
title_full | Performance of 4 Point‐of‐Care Screening Tests for Feline Leukemia Virus and Feline Immunodeficiency Virus |
title_fullStr | Performance of 4 Point‐of‐Care Screening Tests for Feline Leukemia Virus and Feline Immunodeficiency Virus |
title_full_unstemmed | Performance of 4 Point‐of‐Care Screening Tests for Feline Leukemia Virus and Feline Immunodeficiency Virus |
title_short | Performance of 4 Point‐of‐Care Screening Tests for Feline Leukemia Virus and Feline Immunodeficiency Virus |
title_sort | performance of 4 point of care screening tests for feline leukemia virus and feline immunodeficiency virus |
topic | Cats Diagnosis PCR Retrovirus Virus culture |
url | https://doi.org/10.1111/jvim.14648 |
work_keys_str_mv | AT jklevy performanceof4pointofcarescreeningtestsforfelineleukemiavirusandfelineimmunodeficiencyvirus AT pcyndacrawford performanceof4pointofcarescreeningtestsforfelineleukemiavirusandfelineimmunodeficiencyvirus AT sjtucker performanceof4pointofcarescreeningtestsforfelineleukemiavirusandfelineimmunodeficiencyvirus |